CASC
Cascadian Therapeutics, Inc.
CASC
CASC
Delisted
CASC was delisted on the 8th of March, 2018.
1 hedge funds and large institutions have $0 invested in Cascadian Therapeutics, Inc. in 2018 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 90 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
1
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 | -$33.5M | |
| 2 | -$32.3M | |
| 3 | -$11.6M | |
| 4 |
BlackRock
New York
|
-$10.1M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
-$9.2M |
